JPWO2019153009A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019153009A5
JPWO2019153009A5 JP2020564045A JP2020564045A JPWO2019153009A5 JP WO2019153009 A5 JPWO2019153009 A5 JP WO2019153009A5 JP 2020564045 A JP2020564045 A JP 2020564045A JP 2020564045 A JP2020564045 A JP 2020564045A JP WO2019153009 A5 JPWO2019153009 A5 JP WO2019153009A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
regulatory element
segment
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020564045A
Other languages
English (en)
Japanese (ja)
Other versions
JP7381494B2 (ja
JP2021512649A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/016692 external-priority patent/WO2019153009A1/en
Publication of JP2021512649A publication Critical patent/JP2021512649A/ja
Publication of JPWO2019153009A5 publication Critical patent/JPWO2019153009A5/ja
Priority to JP2023188066A priority Critical patent/JP2024012479A/ja
Application granted granted Critical
Publication of JP7381494B2 publication Critical patent/JP7381494B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020564045A 2018-02-05 2019-02-05 転写調節要素及びその使用 Active JP7381494B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023188066A JP2024012479A (ja) 2018-02-05 2023-11-02 転写調節要素及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862626561P 2018-02-05 2018-02-05
US62/626,561 2018-02-05
PCT/US2019/016692 WO2019153009A1 (en) 2018-02-05 2019-02-05 Transcription regulatory elements and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023188066A Division JP2024012479A (ja) 2018-02-05 2023-11-02 転写調節要素及びその使用

Publications (3)

Publication Number Publication Date
JP2021512649A JP2021512649A (ja) 2021-05-20
JPWO2019153009A5 true JPWO2019153009A5 (ru) 2022-02-09
JP7381494B2 JP7381494B2 (ja) 2023-11-15

Family

ID=67478520

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020564045A Active JP7381494B2 (ja) 2018-02-05 2019-02-05 転写調節要素及びその使用
JP2023188066A Pending JP2024012479A (ja) 2018-02-05 2023-11-02 転写調節要素及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023188066A Pending JP2024012479A (ja) 2018-02-05 2023-11-02 転写調節要素及びその使用

Country Status (6)

Country Link
US (1) US20210162073A1 (ru)
EP (1) EP3749756A4 (ru)
JP (2) JP7381494B2 (ru)
CN (1) CN111936621A (ru)
MA (1) MA51753A (ru)
WO (1) WO2019153009A1 (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ760232A (en) 2017-06-07 2023-05-26 Regeneron Pharma Compositions and methods for internalizing enzymes
CN111902539A (zh) * 2018-02-07 2020-11-06 吉尼松公司 杂合调控元件
US10842885B2 (en) 2018-08-20 2020-11-24 Ucl Business Ltd Factor IX encoding nucleotides
WO2021102107A1 (en) * 2019-11-19 2021-05-27 Asklepios Biopharmaceutical, Inc. Therapeutic adeno-associated virus comprising liver-specific promoters for treating pompe disease and lysosomal disorders
EP4107259A1 (en) * 2020-02-18 2022-12-28 Vrije Universiteit Brussel Novel combination of nucleic acid regulatory elements and methods and uses thereof
AR126660A1 (es) * 2021-07-28 2023-11-01 Univ Brussel Vrije Mejorando la eficacia de la terapia génica dirigida a músculos
WO2023173078A2 (en) * 2022-03-11 2023-09-14 Homology Medicines, Inc. Bidirectional dual promoter expression vectors and uses thereof
TW202409290A (zh) * 2022-06-27 2024-03-01 美商安斯泰來基因治療股份有限公司 用於治療肌強直性營養不良之組合物及方法
WO2024074143A1 (en) * 2022-10-08 2024-04-11 Lingyi Biotech Co., Ltd. Construct for enhancing gene expression
CN118064436B (zh) * 2024-04-18 2024-07-26 上海凌医生物科技有限公司 一种增强基因表达的嵌合启动子

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1390490B1 (en) * 2001-05-24 2009-04-15 Genzyme Corporation Muscle-specific expression vectors
US8021875B2 (en) * 2001-08-27 2011-09-20 Roche Madison Inc. Methods for expression of transgenes
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
AU2013277215A1 (en) * 2012-06-19 2015-02-05 University Of Florida Research Foundation, Inc. Compositions and methods for treating diseases
PL3097197T3 (pl) * 2014-01-21 2021-06-28 Vrije Universiteit Brussel Mięśniowo-specyficzne elementy regulatorowe kwasów nukleinowych oraz sposoby i ich zastosowanie
WO2015196179A1 (en) * 2014-06-20 2015-12-23 University Of Florida Research Foundation, Inc. Methods of packaging multiple adeno-associated virus vectors
WO2016172155A1 (en) * 2015-04-23 2016-10-27 University Of Massachusetts Modulation of aav vector transgene expression

Similar Documents

Publication Publication Date Title
RU2018116076A (ru) Модифицированные гены атаксии фридрейха и векторы для генной терапии
JP2020522269A5 (ru)
JP2021106619A5 (ru)
JP2021019591A5 (ru)
JP2022068181A5 (ru)
JP2020533959A5 (ru)
JP2018531609A5 (ru)
TW201704253A (zh) 殼體
JP2007507223A5 (ru)
JPWO2019153009A5 (ru)
JP2017529395A5 (ru)
JP2020509786A5 (ru)
JP7541027B2 (ja) 筋肉発現のためのハイブリッドプロモーター
JPWO2020106916A5 (ru)
JPWO2021077000A5 (ru)
JPWO2019152609A5 (ru)
JPWO2021053222A5 (ru)
FI3177313T3 (fi) Telomeraasi-käänteistranskriptaasipohjaisia hoitoja sydäninfarktiin liittyvien tilojen hoitamiseksi
JP2020533313A5 (ru)
JPWO2019210181A5 (ru)
JPWO2021014428A5 (ru)
AR129014A1 (es) Composiciones y métodos para el tratamiento de distrofias musculares
JPWO2021076911A5 (ru)
JPWO2020214609A5 (ru)
JPWO2020232297A5 (ru)